Ikarian Capital’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

Ikarian Capital’s Portfolio ATXI Stock Details ATXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-140,000	Closed	-$280K	–	229
2024 Q4	$280K	Buy	+140,000	New	+$284K	0.04%	143

Ikarian Capital's ATXI Position: Q1 2025 in Review

Ikarian Capital sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q1 2025, closing a stake of 140,000 shares — an estimated $280K sold.

Ikarian Capital first reported a position in ATXI in Q4 2024 and held it in 1 quarter. The position peaked at $280K in Q4 2024. 0 funds tracked by Wall St. Rank hold ATXI as of Q1 2025.

Ikarian Capital reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Ikarian Capital sold 140,000 Avenue Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $280K.
Ikarian Capital first reported a position in Avenue Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Ikarian Capital's Avenue Therapeutics, Inc. Common Stock position peaked at $280K in Q4 2024.
0 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Ikarian Capital's 13F filing for Q1 2025, filed 15 May 2025.